[1] م. اصغر زاده، ا. پورحاجی، سلول های بنیادی و کاربرد آن ها، فصل نامه آزمایشگاه و تشخیص، شماره 23، ص 39-47، (1393).
[2] Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J. and Clarke M.F., Prospective identification of tumorigenic breast cancer cells, Proceedings National Academic of Science USA.100 (2003) 3983–3988.
[3] Alizadeh A.M., Shiri S. and Farsinejad S., Metastasis review:from bench to bedside, Tumor Biology. 35 (2014) 8483–8543 .
[4] Bahrami-Banan F, Sheikhha M.H, Ghasemi N, Majdizadeh M and Haghiralsadat B.F., Preparation and study of nano-niosomes containing doxorubicin and evaluation of its toxicity on acute myeloblastic leukemia cell line KG-1., Journal of Payavard Salamat. (2018) 309–323.
[5] Bonnet D. and Dick J., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nature Medicine. 3 (1997) 730–737.
[6] Cedars-Sinai Medical Center, stem cell discoveries hold potential to improve cancer treatment: Finding could lead to new ways to fight disease and help patients recover faster, Science Daliy, 25 Jan, www.sciencedaliy.com/2022/01/220125162426.htm (2022).
[7] Das P., Das S., Das P., Rihan F.A., Uzuntarla M. and Ghosh D., Optimal control strategy for cancer remission using combinatorial therapy: A Mathematical model-based approach, Chaos, Solitons and Fractals., https://doi.org/10.1016/j.chaos.2021.110789. (2021).
[8] Guo W., Lasky JL. and Wu H., Cancer stem cells, Pediatric Research. 4 (2006) 59–64.
[9] Jeong Y.D., Kim K.S., Yunil R., Choi S., Iwami S. and Jung H., Optimal feedback control of chemotherapy using Hamilton-Jacobi-Bellman equation, Hindawi, Complexity, Article ID 2158052, 11 page, (2022).
[10] Karkhane M., Marzban A., Rafiei A. and Akhtari J., Cancer Stem Cells:Cell heterogeneity in cancer and nanotechnology approaches for their treatment, Journal of Mazandaran University of Medical Sciences. 26 (2016) 361–375.
[11] Kelly P.N., Dakic A .,Adams J.M.and Nutt SL., Tumor growth need not be driven by rare cancer stem cells, Science. 5836 (2007) 317–337.
[12] Meacci L. and Primicerio M., Mathematical models for tumours with cancer stem cells, Computational and Applied Mathematics, 37 (2018) 6544–6559.
[13] Nikbakht M., Fakharzadeh Jahromi A. and Heydari A., Presentation a mathematical model for prevention of bone metastases progressive by using optimal control, Journal of Operational Research and Applications (Journal of Applied Mathematics). 4 (2016) 47–60.
[14] Persaud S.P., Ritehey J.K., Kim S., Lim S., Ruminski P.G., Cooper M., Retting M.P., Choi J. and Dipersio J.,F., Antibody-drug conjugates plus janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation, Journal of Clinical Investigation. 131(24) (2021) e14550.
[15] Pinch E,R., “Optimal Control and the Calculus of Variations, Oxford University Press, 1995.
[16] Shahabi J., Heidarinasab A., Akbarzadeh A. and Arjmand M., Investigation the efficacy of liposomal nanoparticles containing quantum dots loaded by Doxorubicin anticancer drug in treatment of breast cancer and providing a mathematical model for synthetic of conductance, Journal of Knowledge and Healthin Basic Medical Sciences, 2020.
[17] Suzanne L., Weekes SL., Barker B., Bober S., Cisneros K., Cline J., Thompson A., Hiatky L., Hahnfeldt P. and Enderling H., A multicompartment mathematical model of cancer stem cell driven tumor growth dynamics, Bulletin of Mathematical Biology.76 (2014) 1762–1782.
[18] Termini C.M., Pang A., Li M., Fang T., Chang V.Y. and Chute J.P., Syndecan-2 enriches for hematopoietic stem cells and regulates stem cell repopulating capacity, Journal of Blood. 139 (2022)188–204.
)